SparingVision

0 followers


SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent drug candidate to treat retinitis pigmentosa, the most common inherited retinal d... Read more

Industries

Headquarters

Paris, France

Employees

11-50

Links


Org chart

Stéphane Boissel
President & CEO
Collapse
Mehdi Gasmi
Chief Operating Officer
Marie Uguen
SVP, Regulatory Affairs & QA
Florence Paliargues
VP Portfolio Program Management
Ryan Klimczak
VP, Intellectual Property
Kali Stasi
Chief Medical Officer

Board & advisors

Joseph Papa
Chairman
José Alain Sahel
Scientific Advisor
Thierry Léveillard
Scientific Advisor
Jean Bennett
Scientific Advisor
Paul Sieving
Scientific Advisor
Rusty Kelley
Director
Karen Wagner
Director
Owen Smith
Director
Botond Roska
Scientific Advisor
Elias Arnér
Scientific Advisor
Pierre Chambon
Scientific Advisor
Jacque Duncan
Clinical Advisor
Eric Pierce
Clinical Advisor
Mark Pennesi
Clinical Advisor
Eyal Banin
Clinical Advisor
Masayo Takahashi
Clinical Advisor
Bart Leroy
Clinical Advisor
Dominik Fischer
Clinical Advisor